The American Association for Homeopathic Products

EAS GMP Compliance Seminar
2021-11-10 12:00 - 16:00 (America/New_York)
EAS GMP Compliance Seminar
cGMPs – Important Considerations of HPUS and CFR
Homeopathic manufacturing sites ranked lowest on FDA’s 2019 Site Inspection Scores (SIS). Our industry was rated at 6.5 versus an average across all application types of 7.4. Although the score was affected by many first-time inspections, the industry has work to do.
Learn directly from two former FDA inspectors during this four-hour cGMP seminar. The event will help homeopathic manufacturers prepare for FDA enforcement by facilitating an understanding of compliance requirements from both the Homeopathic Pharmacopoeia of the United States (HPUS) and Code of Federal Regulations (CFR).
What You’ll Learn:

An overview and examples of inspection enforcement.
Requirements for registration, drug listing, and mandatory updates.
How to design an effective Adverse Events Reporting program.
Techniques and practices to provide compliance with manufacturing, packaging, holding, and distribution regulations.

OPENING KEYNOTE
Richard (Rik) Lostritto, PhDAssociate Director for ScienceOffice of Policy for Pharmaceutical Quality (OPPQ)Center for Drug Evaluation and Research (CDER)U.S. Food and Drug Administration (FDA)Hear Dr. Lostritto’s brief opening overview of the importance that agency places on cGMPs. He will be available briefly for questions. This session is an important continuation of the discussion and work being done between FDA and the homeopathic industry. Dr. Lostritto’s views on these pharmaceutical quality issues and necessary compliance considerations will greatly benefit all attendees.Dr. Lostritto joined FDA in 1995 and currently serves as Associate Director for Science in the Office of Policy for Pharmaceutical Quality (OPPQ). Previously, Dr. Lostritto served in the Office of New Drug Quality Assessment (ONDQA) as Acting Deputy Office Director for Science & Policy, Biopharmaceutics Lead, CMC Division Director (oncology, hematology, cardio-renal, neurology, and psychiatric drug products), Team Leader (pulmonary, allergy, and oncology drug products), and Review Chemist in several therapeutic areas. Prior to joining FDA, Dr. Lostritto worked at Boehringer Ingelheim Pharmaceuticals leading a group that developed medical aerosol combination drug products after previously serving as Assistant/Associate Professor of Pharmaceutics at the University of Connecticut School of Pharmacy.
PRESENTERS
Bryan J. ColemanSenior Director for Pharmaceutical & Medical Device Consulting ServicesEAS Consulting Group, LLCBryan Coleman has 30 years of experience in FDA Investigations, pharmaceuticals, and tobacco quality and compliance. Prior to joining EAS, he held various management responsibilities for regulatory compliance, multi-site quality assurance/control operations, and FDA inspections management as a Senior Manager at Altria Client Services, LLC and Director of Quality and Compliance at Pfizer (Wyeth) Consumer Healthcare R&D. His FDA assignments began as a chemist in the Buffalo District and later as an investigator with Baltimore District, where he performed a wide variety of field inspections and investigations operations. He has practical industry experience implementing quality and compliance systems for pharmaceutical, device, dietary supplement, and tobacco operations in both development and production environments. In addition to his civilian roles, Mr. Coleman is a retired Colonel (Combat Engineer, Army National Guard) who held various command and staff assignments, culminating as the Director of Joint Operations overseeing Army and Air National Guard domestic and civil response operations.Robert FishIndependent Advisor, Quality and ComplianceRobert Fish spent 33 years with FDA, the last six years of which as Director, Division of Field Investigations (DFI). He was responsible for general policy and guidance for the Agency’s domestic and international investigation activities. He also managed the foreign inspections’ operations. Mr. Fish is experienced in all aspects of FDA regulated products. He has expertise in compliance matters and cGMP Regulations as they relate to pharmaceutical, device, and biologics manufacture. Further, Mr. Fish is ISO 9000 Lead Assessor Trained and is an AFDO Certified HACCP Instructor. He is a sought-after expert, speaking at international events on FDA inspections and GMPs.Mr. Fish has served as EAS’s lead presenter on cGMPs and has helped a number of homeopathic firms with issues they have faced in the past years.
WHEN
Wednesday, November 10, 2021
12:00 – 4:00 p.m. EST
WHERE
Zoom Webinar
PRICE
$249 per attendee
AAHP Members will receive a $50 rebate following the event.
Register Now
For questions, contact Eric Foxman (info@aahp.info) or Alissa Gould (alissa.gould@boiron.com)
Who Should Attend?
This seminar is a must-attend for domestic and foreign firms who manufacture, label, pack, or hold homeopathic drug products for sale in the United States.

Quality Staff
Legal & Regulatory Staff
Product Leads
Product R&D Staff
Company Leaders (President/CEO)
And those similarly responsible at your contract manufacturer

ABOUT EAS CONSULTING GROUP, LLC
EAS Consulting Group1700 Diagonal Road, Suite 750Alexandria, VA 22314EAS Consulting Group, as part of the Certified Group of companies, has merged with Food Safety Net Services (FSNS) to become the global leader in testing and regulatory solutions for the FDA and USDA regulated industries.EAS’ network of over 200 independent advisors and consultants enables them to provide comprehensive consulting, training, and auditing services, ensuring proactive regulatory and quality compliance for food, dietary supplements, pharmaceuticals, medical devices, cosmetics, tobacco, hemp, and CBD.The merger of FSNS (FSNS.com) with the Certified Laboratories group of companies, (certified-laboratories.com), has created a leading, national testing and regulatory consulting platform. EAS can assist with regulatory and quality requirements and challenges while offering access to a robust scope of testing services to meet organizations’ sophisticated needs.From regulatory strategy, auditing, training, FDA inspection preparation, 483 & Warning letter remediation, quality system implementation, labeling compliance, preparation of technical submissions such as GRAS, Food Additive Petitions, DMFs, NDIs, 510(k)s and more; to FSMA compliance, expert witness services and due diligence assessments, EAS offers the expert knowledge and experience required to ensure compliance through accurate and timely assistance. With our vast expertise in FDA’s and USDA’s policies and enforcement, EAS is the proven choice for assistance with product testing and other regulatory and quality consulting solutions. EASConsultingGroup.com.

AAHP Webinar: Annual Reporting of Quality of Listing Drugs Manufactured
2021-12-10 12:00 - 12:30
Meeting FDA’s New Annual Reporting Requirement

Is your firm ready to meet its new obligation to report quantities of drugs manufactured? Is your staff prepared to provide the level of detailed information in the necessary format for submission? Are you overwhelmed with the thought of tackling this new requirement and submitting the information in the next 10 weeks?
The AAHP brings you a 30-minute webinar to get your company well on its way to fulfilling this task with a minimum of pain and effort. Leonard Krause (of AAHP member FDA Connect) will provide the answers to two fundamental questions:

What is required of your company?
How do you submit the necessary information?

More importantly, Leonard will provide you and your team an overview of the steps and process to comply. With the clear roadmap he provides, your company will find this undertaking less involved and complex than it looks right now.
This reporting requirement applies to your company if it manufactures, repackages, or relabels any drug products, including homeopathic drugs. If these production steps are done on your behalf, your company is still responsible for assuring the reporting is done in a timely manner for your products; otherwise, your products could be at risk.
The reporting requirement is easiest to fulfill when your team understands what information is needed and why; then they can best support the person(s) undertaking the actual reporting task.
What You’ll Learn:

How you need to prepare your company to meet its new FDA reporting obligation
The steps and process needed to be in compliance

Be prepared for the upcoming February 2022 submission deadline as well as the subsequent reporting deadline in May 2022.
This economical 30-minute virtual webinar can be an integral part of your company’s obligatory training to help fulfill your cGMP compliance requirements.
Cost is only $49. AAHP members will receive a full rebate after the webinar.
Sign up here. As many can attend at a registered location as feasible.
PRESENTER
Leonard KrauseFounder and PresidentFDA Connect, Inc.Leonard Krause, founder and president of FDA Connect, Inc., has 30 years’ experience working in the field of government compliance and market research. FDA Connect specializes in serving the homeopathic pharmaceutical industry. This Oregon-based consulting company offers electronic registration and product listing services to FDA on behalf of homeopathic and OTC drug manufacturers and marketers, as well as product label reviews and GNP due diligence audits of CMO’s on behalf of Private Label Distributors. Contact Leonard by phoning 541-232-3030 or by emailing lkrause@fda-connect.com.
WHEN
Friday, December 10
12:00 – 12:30 p.m. EST
WHERE
Zoom Webinar
PRICE
$49 per attendee
AAHP members will receive a full rebate after the webinar.
Register Now
For questions, contact Eric Foxman (info@aahp.info) or Alissa Gould (alissa.gould@boiron.com)
Who Should Attend?

Management and staff responsible for inventory control.
Management and staff responsible for warehousing/shipping.
Management and staff responsible for overseeing sales volumes.
Management and staff responsible for regulatory compliance.
Senior management assuring your company meets its regulatory obligations.

AAHP Annual Membership Meeting
2022-03-23
AAHP Annual Membership Meeting
Due to the ongoing changeableness of travel circumstances, as well as potential uncertainties regarding Natural Products ExpoWest, the Annual Membership Meeting will again be held virtually this year. The virtual meeting will include reports of on-going activities of the AAHP on behalf of our membership and arrangements for election of board members. This is an opportunity for members to delve deeper into issues of importance.
Exclusive to AAHP Members is this annual briefing on the latest legal and regulatory issues from AAHP Legal Counselor Al Lorman, Esq. and on federal programs affecting your business from AAHP Lobbyist Pete Evich of Van Scoyoc Associates. Emerging issues and critical topics will be addressed as necessary by expert guest speakers. Additionally, AAHP officers will provide updates on association projects, and elections for Board seats will be held. AAHP Members are encouraged to invite your government affairs team, quality assurance team, marketing team, R&D team, and CEO.
Details are currently being finalized and will be communicated to members.
What You’ll Learn:

The latest legal and regulatory issues
Federal programs that may be affecting your business
Emerging issues
Updates on association projects

PRESENTERS

Al Lorman, Esq.AAHP Legal CounselorLaw Office of Alvin J. LormanPete EvichAAHP LobbyistVan Scoyoc AssociatesAdditional presenters to be announced.
WHEN
Wednesday, March 23, 2022
12:00 – 2:00 p.m. EST
WHERE
Virtual Zoom Meeting
PRICE
Free to AAHP members, closed to non-members.

Register Now

Who Should Attend?
CEOsQuality assurance teamsGovernment affairs teamsMarketing teamsRegulatory and distribution teams
Within a day after you register, you will receive a confirmation email containing information about joining the Annual Members Meeting. You may register as long in advance as you wish; registrants will also receive a reminder email with the how-to-join information 24 hours and again one hour prior to the Annual Members Meeting.
Registration can be done up until 10 minutes prior to the start of the Annual Members Meeting (9:00 am PDT). This will allow the necessary interval to approve and return the confirmation email. Within that 10 minute interval, we can not guarantee you will receive the email in time.
For questions, contact Eric Foxman (info@aahp.info) or Alissa Gould (alissa.gould@boiron.com)

What's New in the HPUS and What's Coming?
2022-06-08 12:00 - 12:30
2021-22 HPUS Updates Webinar
This short webinar will present the recent additions and changes to monographs in the HPUS, including revised attenuation levels, updates to quality control methods, and specifications. The status of the ongoing “Technical Gaps” project will also be presented. Additionally, an overview of the HPUS website redesign, which began recently, will be given and attendees will have an opportunity to provide input regarding content and layout changes that will make your use of the pharmacopoeia more efficient and helpful.
FDA’s revised Draft Guidance makes clear the agency’s definition of what is and what is not homeopathic is based on the contents of the HPUS. Don’t be caught with outdated formulations and products as monographs and compendial guidelines are updated. FDA will be comparing your processes and formulas against what is officially included in the HPUS. This makes it more important than ever for your company to be in-the-know regarding changes and updates in the HPUS.
Attend this half-hour webinar for an overview of these changes, where attendees can receive documents following the webinar that list the monographs affected by these updates.
Whether you manufacture or market homeopathic drug products, the changed information in the HPUS has a bearing on your products’ compliance status. Regulatory and FDA reviews of homeopathic products over the past year support the critical importance of being current with the updates in the HPUS. These changes and updates may affect your business, your cGMP compliance, your products, and your long-term success in the market!

Who Should Attend

Compliance Managers
Quality Control And Quality Assurance Managers
Staff Responsible For Product Formulations
Staff Responsible For Product and Label Review
Marketing Staff
CEOs and Senior Management

Presented By
Eric Foxman, Pharm. (Ret.)
For more 40 years, Eric Foxman, Pharm. (Ret.) has been involved with the HPCUS in many capacities, including its Board, and as chair of the Council on Pharmacy. In this latter role, Eric has helped with the review and revision of compendial documents to keep them current with contemporary cGMP expectations.
Many in the industry know Eric Foxman as a member or company representative of the American Association of Homeopathic Pharmacists dating back to 1979. He is in the 11th year (in his fourth round) on the Board of Directors. Eric has been a presenter or host of numerous AAHP Compliance Thru Education webinars addressing legal, regulatory and technical aspects of the manufacture and marketing of homeopathic drug products; this is Eric’s ninth annual webinar on HPUS Updates.
WHEN
June 8, 2022
12:00 p.m. EDT
PRICE
Members: Free
Non-Members: $49
REGISTER NOW
“*” indicates required fields
Event Ticket
AAHP Member Ticket
Non-Member Ticket
First Name* Last Name* Email* Company* Title* Zip Code* Total Payment Method
PayPal Checkout
MasterCardVisaSupported Credit Cards: MasterCard, Visa Card Number Expiration Date Security Code Cardholder Name

Registration Information

Each webinar registration is for one computer/phone connection.
If it is physically possible at your location, more than one participant may view the live webinar with no additional registration fee.
The registration fee has been purposefully kept low to make it possible for multiple employees of a company to attend at separate locations.
Each registration will automatically receive one (1) certificate of participation issued in the name of the registered participant. If you would like additional certificates of participation, please send an email to info@aahp.info to indicate how many additional certificates you wish to purchase at $39 each; you will be contacted after the event for the names to be printed on the additional certificates and to arrange for payment through PayPal.
For more information regarding the seminar, contact Eric Foxman by calling 1-503-659-2715 or by emailing info@aahp.info.

HRI Online 2022: Key Collaborations in Homeopathy Research
2022-06-25
HRI Online 2022: Key Collaborations in Homeopathy Research
AAHP proudly supports the Homeopathy Research Institute’s first virtual summit reporting on advances in high-quality scientific research on homeopathy from around the world. Attendees will hear from 12 keynote-level speakers from eight countries on four continents – all of whom have headlined at previous HRI conferences or other international conferences. (All presentations will be in English.)
To register or for more information about the event, visit www.HRI2022.org or email Events@HRI-Research.org. HRI is a UK-based charity dedicated to promoting high-quality research in homeopathy at an international level.
What You’ll Learn:

Developments on raising the quality of homeopathic research and communicating the progress.
An evolution of homeopathic basic research models at the University of Bern.
A collaboration between Israeli and Indian colleagues to conduct a randomized controlled trial.
Overcoming barriers to homeopathy research.
How practitioners can assist in data collection, which will improve their practice as well as demonstrate the value of homeopathy.
Experiences from decades at the forefront of integrative oncology.
Homeopathy research in Brazil; 25 years of progress.
A brief introduction and overview of leading organizations conducting research on homeopathy.

WHEN
Saturday, June 25, 2022
Full day
WHERE
Virtual
PRICE
Early bird rate: £49 (Approx. $65 USD) until Sunday, March 27
AAHP members: To receive a 10% discount on the registration fee. Conact Info@AAHP.org for a members-only registration code.
Register Now
For questions, contact Eric Foxman (info@aahp.info) or Alissa Gould (alissa.gould@boiron.com)
Who Should Attend?

Manufacturers, scientists, clinicians, educators, practitioners, and consumers.
Those needing CPE/CPD credits (estimated learning time is 7 hours).
Everyone wanting to submit questions to the leading international experts in homeopathic research.

MEET YOUR SPEAKER
Rachel Roberts, BSc(Hons), MCH, RSHom, FSHom, FFHom(Hon), is Chief Executive of the Homeopathy Research Institute (HRI), a UK-based charity dedicated to promoting high quality research in homeopathy at an international level. HRI is committed to accurate communication of the evidence base in homeopathy and promoting new essential research projects of the highest quality.

Rachel has a first class honours degree in Biological Sciences (Physiology) from the University of Birmingham. She graduated from the College of Homeopathy, London in 1997 and was in private clinical practice until 2012. Rachel lectured in both homeopathy and medical sciences at various colleges in the UK and overseas before moving into the field of homeopathy research. She held the post of Research Consultant for the Society of Homeopaths from 2008-2012 and was awarded an Honorary Fellowship in 2013 to acknowledge her contribution to Homeopathy. Rachel joined HRI part-time in 2010 and has worked for the Institute full-time since 2012. In 2018 Rachel was awarded an Honorary Fellowship by the Faculty of Homeopathy in recognition of her work in the field of homeopathic research.
HRI is an innovative international charity created to address the need for high quality scientific research in homeopathy. The charity was founded by physicist, Dr Alexander Tournier, who previously worked as an independent researcher for Cancer Research UK, conducting interdisciplinary research at the boundaries between mathematics, physics and biology.

Industry Reception, Award Presentation, and Dinner
2022-09-29 | The Union League of Philadelphia, 1450 Sansom St, Philadelphia, PA, 19102, United States
Industry Reception, Award Presentation, and Dinner
In-Person and Virtual Options!
Join us for this complimentary and in-person event at the historic Union League of Philadelphia, or view it virtually. Just a 5-block walk from Natural Products Expo East and a 10-minute cab ride from Amtrak’s 30th Street Station.Designed to connect and support retailers who champion the industry’s products with manufacturers, this event brings together senior executives from the homeopathic industry and professionals from adjacent associations before hearing the Integrative Medicine Retailer award winner share retail initiatives for natural products.
Integrative Medicine Retailer Award Presented to H-E-B
Hear about this San Antonio-based retailer’s many unique programs to help consumers navigate their health journeys. Mike Schaeffer, Director, Drug Store, will be accepting the award on behalf of H-E-B as it strives to be a one-stop health-and-wellness destination. The Integrative Medicine Retailer Award has been previously accepted by Wegmans Food Markets, Rite Aid, and Meijer, Inc.
Agenda
Please note virtual programming begins at 6:00 p.m.

5:30 p.m.: In-person networking kicks off.
6:00 p.m.: Welcome by Mark Land, MS, RAC, AAHP President.
6:10 p.m.: “Future Consumers, Future Markets” presented by Troy Beeler, Co-Founder and General Manager, Future Commerce Initiative.
6:40 p.m.: AAHP Award to H-E-B accepted by Mike Schaeffer, Director, Drug Store.
7:00 p.m.: Dinner following reception.

Venue
The Philadelphia Union LeagueThe Meade Room, 1st Floor1450 Sansom StreetPhiladelphia, PA 19102The Union League of Philadelphia is ranked the #1 City Club in the Country. Founded in 1862 as a patriotic society to support the Union and the policies of President Abraham Lincoln, the League has hosted U.S. presidents, heads of state, industrialists, entertainers, and dignitaries from around the globe and has proudly supported the American military in each conflict since the Civil War. Today its 4,000 members represent Philadelphia leaders in every sector. Join AAHP in its unique event room with a distinguished collection of art and artifacts adorning the walls and hallways recognized by historians and art experts as a valuable component of American history. Business attire required. View The Union League Dress Code here.

When
September 29, 2022In-Person programming begins at 5:30 p.m. ESTVirtual programming begins at 6:00 p.m. EST

Where
The Philadelphia Union LeagueThe Meade Room, 1st Floor1450 Sansom Street, Philadelphia, PA 19102Business attire required. View The Union League Dress Code here.

Price
Complimentary and open to non-members.

Registration
Registration required. See options below for in-person and virtual registration forms.

Register Now:
In Person Registration Expand

Virtual Registration Expand

For questions, contact Eric Foxman (info@aahp.info) or Alissa Gould (alissa.gould@boiron.com)
Featured Speaker Future Consumers, Future MarketsPresented by Troy Beeler
Troy is the co-founder and general manager of the The Future Commerce Initiative (FCI). FCI educates and advises today’s senior commercial leaders in retail and consumers products organizations in the future of commerce and work. FCI’s uniqueness is its well-grounded casework, faculty, and engaged alumni. Before FCI, Troy was an early team member at RetailNet Group (RNG), an advisory and insights firm that works with leading retailers and consumer brands worldwide. During his time at RNG, Troy ran the Advanced Retail Strategy Program, an executive education program taught at the UCLA Anderson School of Management with more than 1,500 alumni from 20+ countries. (RNG sold to Ascential Insight, PLC in 2015.) Troy started his career with the Grocery Manufacturers of America (now called the Consumer Brands Association) in Washington, DC.
Presenting Sponsor
The Emerson Group is a consumer products equity organization focused on accelerating mid-market brand growth. It also operates internationally, providing partners in the European, South American and Asian Pacific regions with the expertise and infrastructure necessary to successfully operate in the U.S. market. An Emerson Group division, Emerson Logistics is a consumer products logistics solutions provider. A third division, Emerson Marketing, is an analytics and insights-based consumer products communications organization.

AAHP Semiannual Membership Meeting 2022
2022-10-13 14:00 - 15:30
AAHP Semiannual Membership Meeting
Join Us This Fall
This member-exclusive meeting will cover all the latest legal and regulatory matters. With more than three decades of experience in the homeopathic industry, AAHP Legal Counsel Al Lorman, Esq. will provide members with an intimate look at such issues. Also in attendance will be AAHP lobbyist Pete Evich of Van Scoyoc Associates, who will give a first-hand overview of federal programs impacting businesses. Members will also get an exclusive update on ongoing association projects. AAHP Members are encouraged to invite your government affairs team, quality assurance team, marketing team, R&D team, and CEOs.
Who Should Attend

Government Affairs Teams
Quality Assurance Teams
Marketing Teams
R&D Teams
CEOs

When
Thursday, October 13, 2022 2-3:30 p.m. EDT

Where
Zoom Virtual Meeting

Price
AAHP Members: FreeClosed to Non-Members

Register Now:
Registration Expand

For questions, contact Eric Foxman (info@aahp.info) or Alissa Gould (alissa.gould@boiron.com)

AAHP Annual Membership Meeting
2023-03-16 11:00 - 12:30
AAHP Annual Membership Meeting

Join Us in the Spring

Exclusive to AAHP Members is this annual briefing on the latest legal and regulatory issues from AAHP Legal Counselor Al Lorman, Esq. and on federal programs affecting your from AAHP Lobbyist Pete Evich of Van Scoyoc Associates. This is your opportunity to hear updates and participate in discussions on FDA’s finalized guidance on homeopathy; AAHP’s cGMP Summit 2023 on work with HPCUS to build compliance and a relationship with FDA by working on regulatory and technical ambiguity in the manufacturing process; and the association’s changes and celebrations for its centennial year. Additionally, AAHP officers will provide updates on association projects and activities. Board elections will be held; those interested in running, please contact the AAHP Office. AAHP Members are encouraged to invite your government affairs team, quality assurance team, marketing team, R&D team, and CEO.

When
Thursday, March 16, 202311 a.m. – 12:30 p.m. EST

Where
Zoom Virtual Meeting

Price
AAHP Members: FreeClosed to Non-Members

Register Now

For questions, contact Eric Foxman (info@aahp.info) or Alissa Gould (alissa.gould@boiron.com)

Who Should Attend

Government Affairs Teams Quality Assurance Teams Marketing Teams R&D Teams CEOs

AAHP: 100 Years Promoting Quality, Integrity, and Trust in Homeopathic Medicines
2023-03-24 12:00 - 13:00
AAHP: 100 Years Promoting Quality, Integrity, and Trust in Homeopathic Medicines

AAHP Board Member and Secretary Eric Foxman will present “AAHP: 100 Years Promoting Quality, Integrity, and Trust in Homeopathic Medicines” in celebration of the association’s centennial year at the 2023 Joint American Homeopathic Conference (JAHC). Join Eric during the conference lunch on Friday, March 24, at Noon MDT. If attending in person, be sure to say hello to Eric at the AAHP booth in the exhibit hall. The JAHC takes place Friday through Sunday, March 24-26, 2023, at the Holiday Inn Riverwalk, San Antonio, TX. Many of the events will also be live-streamed. See the full event schedule and register at www.JAHC.info.

Featured Speaker

Eric Foxman, Pharm. (Ret.)Eric Foxman, Pharm. (Ret.) of Eric L. Foxman Consulting in Milwaukee, OR, is known to many in the industry as a member or company representative of AAHP dating back to 1979. Since 2010 (for four terms), he has served on the Board of Directors. Eric has been a presenter or host of numerous AAHP Compliance Thru Education webinars, addressing legal, regulatory, and technical aspects of the manufacturing and marketing of homeopathic drug products. He has also been involved with the Homeopathic Pharmacopoeia Convention of the United States (HPUS) for more than 40 years, serving on its Board, and as chair of the Council on Pharmacy. In this latter role, Eric has helped with the review and revision of compendial documents to keep them current with contemporary cGMP expectations.

When
Friday, March 24, 202312:00 pm-1:00 pm EDT

Where
Joint American Homeopathic ConferenceHoliday Inn RiverwalkSan Antonio, TXVirtual Attendance Available

Register Now

For questions, contact Eric Foxman (info@aahp.info)

AAHP Open-to-Industry Town Hall
2023-06-27 12:00 - 13:00
AAHP Open-to-Industry Town Hall

Together, we will delve into the most pressing issues that impact our industry and explore potential solutions. We urge you to participate. Whether you are a manufacturer, labeler, distributor, formulator, or marketer, your contributions are valuable.The Town Hall will offer multiple avenues for engagement: a pre-event survey to collect questions in advance, allowing our panel of experts to provide insightful answers, as well as live participation during the event, enabling dynamic exchanges of ideas and perspectives.Register now to secure your spot in this vital conversation!

When
Tuesday, June 27, 202312:00 – 1:00 p.m. EST

Where
Zoom Virtual Meeting

Price
Free to both AAHP members and non-members

Register Now For questions, contact Alissa Gould,AAHP Volunteer Communications Chair,Alissa.Gould@Boiron.com; 610-325-8321 Who Should Attend

Regulatory Affairs Teams
Quality Assurance Teams
Marketing Teams
Manufacturing Personnel
CEOs

HRI State of Research for Homeopathy 2023
2023-09-20 12:00 - 13:00
HRI State of Research for Homeopathy

AAHP’s most popular webinar is back! The Homeopathic Research Institute’s Chief Executive and one of the world’s leading homeopathic research experts Rachel Roberts will present an updated encore of her sold-out lecture from nearly three years ago.
Learn From the Expert
Many in the homeopathy sector say there is “loads” of evidence homeopathy works. Detractors say there is no evidence at all that homeopathy is anything more than a placebo effect. As is often the case, the reality is in between these extremes. In this presentation we will look at the true status of the clinical evidence base for homeopathy – including both its strengths and weaknesses – as well as identifying where some of the frequently repeated myths surrounding this topic originate, so they can be firmly dispelled.
Event Information
Virtual Only
Wednesday, Sept. 20, 2023 from 12:00pm-1:00pm EDT
Cost: $49 AAHP member, $69 AAHP non-member
Register and pay here through Zoom.
Rebate will be sent to members after the event.
100% of proceeds will be donated to the Homeopathic Research Institute.
Register early to secure one of the limited spots.

This event has passed. Thank you to all who attended. Please stay tuned for future events.

About the Speaker
Rachel Roberts, BSc(Hons), MCH, RSHom, FSHom, FFHom(Hon), is Chief Executive of the Homeopathy Research Institute (HRI), a U.K.-based charity dedicated to promoting high-quality scientific research in homeopathy at an international level.
Rachel has a first-class honours degree in Biological Sciences (Physiology) from the University of Birmingham. She graduated from the College of Homeopathy, London in 1997 and was in private clinical practice until 2012. Rachel lectured in both homeopathy and medical sciences at various colleges in the U.K. and overseas before moving into the field of homeopathy research. She held the post of Research Consultant for the Society of Homeopaths from 2008-2012 and was awarded an Honorary Fellowship in 2013 to acknowledge her contribution to homeopathy. Rachel joined HRI part-time in 2010 and has worked for the Institute full-time since 2012. In 2018 Rachel was awarded an Honorary Fellowship by the Faculty of Homeopathy in recognition of her work in the field of homeopathic research.
About Homeopathy Research Institute
HRI is an innovative international charity created to address the need for high-quality scientific research in homeopathy. This U.K.-based organization is committed to accurate communication of the evidence base in homeopathy and promoting new essential research projects of the highest quality. The charity was founded by physicist, Dr Alexander Tournier, who previously worked as an independent researcher for Cancer Research U.K., conducting interdisciplinary research at the boundaries between mathematics, physics and biology.
What You Can Do Toward Homeopathic Research
AAHP stresses the importance of supporting HRI’s work. Please donate directly to HRI through: hri-research.org/Donate.

Industry Reception 2023
2023-09-20 17:30 - 20:00 | The Union League of Philadelphia, 1450 Sansom St, Philadelphia, PA, 19102, United States
Industry Reception 2023

This event has concluded. Thank you to all who attended. Please stay tuned for future events!

In-Person and Virtual Options!

Join us for this complimentary and in-person event at the historic Union League of Philadelphia, or view it virtually.Designed to connect and support retailers who champion the industry’s products with manufacturers, this event brings together senior executives from the homeopathic industry and professionals from adjacent associations before hearing the Integrative Medicine Retailer Award winner share retail initiatives for natural products.

Integrative Medicine Retailer Award Presented to Walgreens

Michael Wolf, PharmD, The Walgreen Company’s Senior Director/Divisional Merchandise Manager, OTC Drugs, will be onsite accepting the award. Drawing on his 20 years as a valued leader of the Walgreens team, Mike will give an overview of the company’s OTC drug strategy to deliver expertise, convenience, and value to its customers. He will also share how the trusted superstore links its priorities to defining its customers as cost conscious, digitally savvy, proactive, and evolving.The Integrative Medicine Retailer Award has been previously accepted by Wegmans Food Markets, Rite Aid, Meijer, Inc., and H-E-B.

Agenda

Please note virtual programming begins at 6:15 p.m. EDT. 5:30 p.m.: In-person networking kicks off.6:15 p.m.: Welcome by Mark Land, MS, RAC, AAHP President.6:25 p.m.: “Exploring Teaching Homeopathy in U.S. Pharmacy Schools” presented by William R. Doucette, Ph.D., Deborah K. Veal Professor in Health-Care Policy, College of Pharmacy, University of Iowa.6:45 p.m.: AAHP Award to Walgreens accepted by Michael Wolf, PharmD, Senior Director/Divisional Merchandise Manager, OTC Drugs.7:10 p.m.: Dinner following reception.

Venue

The Philadelphia Union LeagueThe Lincoln Memorial Library Lounge, 2nd Floor1450 Sansom StreetPhiladelphia, PA 19102The Union League of Philadelphia is ranked the #1 City Club in the Country. Founded in 1862 as a patriotic society to support the Union and the policies of President Abraham Lincoln, the League has hosted U.S. presidents, heads of state, industrialists, entertainers, and dignitaries from around the globe and has proudly supported the American military in each conflict since the Civil War. Today its 4,000 members represent Philadelphia leaders in every sector. Join AAHP in its unique event rooms with a distinguished collection of art and artifacts adorning the walls and hallways recognized by historians and art experts as a valuable component of American history.Business attire required. View The Union League Dress Code here.

When
September 20, 2023In-Person programming begins at 5:30 p.m. EDTVirtual programming begins at 6:15 p.m. EDT

Where
The Philadelphia Union LeagueThe Lincoln Memorial Library Lounge, 2nd Floor1450 Sansom Street, Philadelphia, PA 19102Located a short five-block walk from Natural Products Expo East and a 10-minute cab ride from Amtrak’s 30th Street Station.

Price
Complimentary and open to AAHP members and non-members.

Registration
Registration required. See options below for in-person and virtual registration forms.

Photo/Video Waiver Release
For questions, contact Alissa Gould (alissa.gould@boiron.com)

Featured Speaker

Exploring Teaching Homeopathy in U.S. Pharmacy SchoolsPresented by William R. Doucette, Ph.D.Dr. Doucette is the Deborah K. Veal Professor in Health-Care Policy in the Department of Pharmacy Practice & Science at the University of Iowa in Iowa City. His research interests include ways that pharmacists, especially in the community, can influence medication use. Bill is currently working to publish a study of data collected in Winter 2021-2022 on the status of homeopathy being taught in U.S. pharmacy schools. The study emphasized preparing pharmacists to be reliable sources of information for patients when they ask about homeopathic products. If published, the study would be just one of nearly 200 peer-reviewed publications in which he has been involved. As a professor, he hopes to advance ways that pharmacists can help patients take their medications safely and effectively.

Presenting Sponsor

The Emerson Group is a consumer products equity organization focused on accelerating mid-market brand growth. It also operates internationally, providing partners in the European, South American and Asian Pacific regions with the expertise and infrastructure necessary to successfully operate in the U.S. market. An Emerson Group division, Emerson Logistics is a consumer products logistics solutions provider. A third division, Emerson Marketing, is an analytics and insights-based consumer products communications organization.

AAHP 2023 Semiannual Membership Meeting
2023-10-12 12:00 - 14:00
AAHP Semiannual Membership Meeting

Exclusive to AAHP Members is this semiannual briefing on the latest legal and regulatory issues from AAHP Legal Counselor Al Lorman, Esq. and on federal programs affecting your business from AAHP Lobbyist Pete Evich of Van Scoyoc Associates. Emerging issues and critical topics will be addressed. Additionally, AAHP officers will provide updates on association projects.
Event Information
Virtual Only
Thursday, Oct. 12, 2023 from 12:00pm-2:00pm EDT
Complimentary to AAHP Members, but registration is required
Closed to non-members
Please do not de-value your membership by sharing the link with non-members.

Registration

Member Priorities Survey

Questions from members are welcomed prior or during the event. Please contact AAHP Volunteer Communications Chair Alissa Gould via email at Alissa.Gould@Boiron.com or by voice message at 610-325-8321.
Who Should Attend at AAHP Member Companies

Government Affairs Team
Compliance Officers and Quality Assurance Team
Lab and Production Managers
Marketing Team
R&D Team
Company Executives, including CEOs

Discussion and Report Topics

Potential Research Projects
Organization Identity
GMP Compliance Issues
Member Activities
Status of the Association’s Education Projects
Update on AAHP 100th Anniversary Activities
Semiannual Review of Regulatory and Legislative Activities

AAHP GMP Compliance Seminar
2023-10-18 12:00 - 16:00
AAHP GMP Compliance Virtual Seminar

The American Association of Homeopathic Pharmacists is excited to present a virtual seminar on Good Manufacturing Practices (GMP) for our industry. This event is open to both AAHP members and non-members.
3 Crucial Topics Discussed in Depth
This half-day cGMP seminar will help homeopathic manufacturers prepare for Food and Drug Administration (FDA) inspection by facilitating an understanding of compliance requirements from both the Homeopathic Pharmacopoeia of the United States (HPUS), Code of Federal Regulations (CFR), and FDA. Learn about the most pressing enforcement topics and microbiological requirements for your products.
Tamara L. Ely, Branch Chief, FDA Office of Manufacturing Quality, Office of Compliance
Overview of recent enforcement actions against homeopathic products and FDA cGMP guidance documents.
Stephen E. Langille, Ph.D., Senior Microbiology Consultant at ValSource, Inc. and former Director of FDA CDER’s Division of Microbiology Assessment
Discussion on one of the most common reasons for an FDA warning letter to manufacturers of homeopathic products: microbial contamination in non-sterile drug products.
George Bernstein, Ph.D., Industry Consultant
Review of easily-overlooked GMP requirements in the HPUS intended to specifically supplement pharmaceutical cGMPs for homeopathic drug products.
By knowing what FDA takes into consideration, homeopathic manufacturers can better prepare for inspections and minimize their impact on day-to-day business activities. Ultimately, this crucial education leads to manufacturing excellence and the production of the safest and highest-quality homeopathic products.

Tickets

Agenda

Event Information
Virtual Only
Wednesday, Oct. 18, 2023 from 12:00pm-4:00pm EST
Cost: $199-499
Open to non-members; AAHP members receive a discount.
ENTERPRISE TICKET PURCHASES: You will receive a confirmation email with instructions to register your remaining attendees following your transaction.
What You Will Learn

Overview and examples of inspection enforcement.
GMP requirements specifically for homeopathic products from the HPUS.
Design of an effective QC program.
Microbiological quality standards for non-sterile products.
FDA hot topics.

Who Should Attend
This seminar is a must-attend for domestic and foreign firms who manufacture, label, pack, or hold homeopathic drug products for sale in the United States.

Quality Staff
Legal & Regulatory Staff
Product Leads
Product R&D Staff
Company Leaders (President/CEO)
And those similarly responsible at your contract manufacturer

Please contact AAHP Volunteer Communications Chair Alissa Gould via email at Alissa.Gould@Boiron.com or by voice message at 610-325-8321.

Tickets

Agenda
All times below are in Eastern Daylight Time.

12:00-12:10pm
Mark Land, M.S., RAC – Welcome from AAHP

12:10-1:10pm
George Bernstein, Ph.D. – A Look at GMP Requirements in the HPUS

1:10-1:25pm
Break

1:25-2:25pm
Stephen Langille, Ph.D. – Microbial Contamination

2:25-2:40pm
Break

2:40-3:40pm
Tamara Ely – Compliance Trends

3:40-3:50pm
Mark Land, M.S., RAC – Closing

About the Speakers
George Bernstein, Ph.D.
A Look at GMP Requirements in the HPUSPresented by George Bernstein, Ph.D.President, MAI Consulting, Inc.
George Bernstein, Ph.D., is President of MAI Consulting, Inc., a consulting firm located in North Carolina. Dr. Bernstein has a Ph.D. in chemical engineering and more than 30 years of experience in pharmaceutical manufacturing, laboratory operations, data integrity, effective training, and quality risk management. Since 1988, Dr. Bernstein has consulted internationally with major pharmaceutical companies. He has lectured internationally on quality systems and root cause analysis to industry trade groups, quality organizations, including the Parenteral Drug Association and at Interphex conferences.
Dr. Bernstein’s experience, insights, and innovative problem solving have been integral to his work, which ranges from training effectiveness, GMP compliance, facility design, construction, and commissioning to business process re-engineering and process optimization. He has developed global quality standards (GLP, GCP, GPP) for a major international pharmaceutical company, and has assisted many clients with audit preparation, remediation activities, and communications with the U.S. FDA.
Dr. Bernstein recently authored the following articles on LinkedIn: “FDA and Data Integrity – 3 Perspectives,” “API Manufacturing and Data Integrity – an Auditor’s Perspective,” “So, You Want to be a Consultant? Really?” and “Training Compliance vs. Training Effectiveness.” Additionally, Dr. Bernstein is a strong proponent of homeopathy.
Stephen E. Langille, Ph.D.
Microbial ContaminationPresentation by Stephen E. Langille, Ph.D.Senior Microbiology Consultant, ValSource, Inc.
As a senior microbiology consultant at ValSource, Inc., Dr. Langille specializes in microbiological and particulate matter contamination control. Prior to this position, he spent 19 years with FDA as a microbiology reviewer, branch chief, and director of the Division of Microbiology Assessment in the Center for Drug Evaluation and Research.
Dr. Langille is a member of the United States Pharmacopeia and Parenteral Drug Association working groups on particulate and microbiological manufacturing control and participating in the writing of the FDA’s draft guidance on Microbiological Quality Considerations in Non-sterile Drug Manufacturing.
With a B.S. degree in biology from the University of Massachusetts, Dr. Langille earned his Ph.D. in microbiology from the University of Maryland.
Tamara L. Ely
Compliance TrendsPresented by Tamara L. ElyBranch Chief, Branch 6, Office of Manufacturing Quality, Office of Compliance, Center for Drug Evaluation and Research
Ms. Ely received a bachelor’s degree in chemistry from West Virginia University in 1996 and a master’s degree in quality assurance and regulatory affairs from Temple University’s School of Pharmacy in 2005. She began instructing at Temple University in 2015. As an Adjunct Associate Professor, she co-instructs a course on Microbiological Concepts for Pharmaceuticals and Current Good Manufacturing Practices.
In her career, Ms. Ely has held various quality and compliance positions within the pharmaceutical industry: analytical chemist, certified quality auditor, compliance reviewer, CGMP and validation consultant.
Since 2010, Ms. Ely has worked in the Office of Manufacturing Quality in the Center for Drug Evaluation and Research (CDER) reviewing administrative and regulatory actions regarding adulteration, evaluating inspectional findings, and determining the acceptability of manufacturing facilities. In this role, she also participates in the development of science-based regulatory policy and guidance.

Register

Early bird pricing is available through September 28, 2023 at 11:59pm EDT.

AAHP 2024 Annual Membership Meeting
2024-03-08 12:00 - 14:00
AAHP Annual Membership Meeting

Exclusive to AAHP Members is this annual briefing on the latest legal and regulatory issues from AAHP Legal Counselor Al Lorman, Esq. and on federal programs affecting your business from AAHP Lobbyist Pete Evich of Van Scoyoc Associates. Emerging issues and critical topics will be addresssed as necessary. Additionally, AAHP officers will provide updates on association projects.
Event Information

Virtual Only
Friday, March 8, 2024 from 12:00pm-2:00pm EDT
Complimentary to AAHP Members, but registration is required
Closed to non-members

Please do not de-value your membership by sharing the link with non-members.
Who Should Attend at AAHP Member Companies

Government Affairs Team
Compliance Officers and Quality Assurance Team
Lab and Production Managers
Marketing Team
R&D Team
Company Executives, including CEOs

Questions from members are welcomed prior or during the event. Please contact AAHP Secretary Eric Foxman at email at Info@AAHP.Info or by voice message at 513-402-8847.

Water Treatment Systems Seminar
2024-06-12 12:00 - 16:00
AAHP Water Treatment Systems Seminar

The American Association of Homeopathic Pharmacists is excited to present a virtual seminar on Water Treatment Systems for our industry. This event is open to both AAHP members and non-members.
3 Crucial Topics Discussed in Depth
A half-day cGMP seminar focused on one of the most common reasons for an FDA warning letter regarding homeopathic products: microbial contamination in non-sterile drug products. The webinar will facilitate a better understanding of water treatment system design and compliance requirements. It will help you improve product quality and be well prepared for FDA inspections.
William Yang, Ph.D., Consumer Safety Officer, FDA CDER
Discussion on trends in CGMP deviations and violations pertaining to pharmaceutical water purification systems noted in recent FDA drug warning letters.
Christine Craig, Ph.D., Microbiology Consultant, ValSource, Inc.
Discussion on microbiological control of water treatment systems.
Josh Capsavage, Senior Business Development Manager, Xylem
Practical overview and engineering perspective on designing water treatment systems.
Understanding water treatment systems design and what FDA takes into consideration is essential for all ongoing cGMP compliance efforts for all products produced using water. Mastering these focus areas will also better prepare your company for inspections and minimize potential impact on your day-to-day business activities. Ultimately this crucial education leads to manufacturing excellence and the production of safe, high quality, and pharmaceutical-grade homeopathic products. It also helps your company meet its compliance with statutory requirements for ongoing employee education.

Tickets

Agenda

Event Information
Virtual Only
Wednesday, June 12, 2024
from 12:00 p.m. (9 a.m. PDT) – 4:00 p.m. EDT (1 p.m. PDT)
Open to non-members; AAHP members receive a discount.
What You Will Learn

Overview and examples of inspection enforcement.
GMP requirements for water treatment systems.
Design of an effective water treatment system.
Microbiological quality standards for pharmaceutical water systems.
FDA hot topics.

Who Should Attend
This seminar is a must-attend for all domestic and foreign firms who manufacture, label, pack, or hold homeopathic drug products for sale in the United States. Individuals who will find it worthwhile include:

Quality Staff
Legal & Regulatory Staff
Product Leads
Product R&D Staff
Company Leaders (President/CEO)
And those similarly responsible at your contract manufacturer

Please contact AAHP Secretary Eric L. Foxman via email at Info@AAHP.Info or by voice message at 513-402-8847 with questions.

Tickets

Agenda
All times below are in Eastern Daylight Time.

12:00-12:10pm
Mark Land, M.S., RAC, AAHP – Welcome

12:10-1:10pm
Christine Craig, Ph.D., Valsource, Inc. – Microbiological Control of Water Treatment Systems

1:10-1:25pm
Break

1:25-2:25pm
Josh Capsavage, Xylem Water Technologies – Water Treatment System Design

2:25-2:40pm
Break

2:40-3:40pm
William Yang, Ph.D., FDA – Recent CGMP Deficiency Trends in Pharmaceutical Water Purification Systems

3:40-3:50pm
Mark Land, M.S., RAC, AAHP – Closing

About the Speakers
Christine Craig, Ph.D.

Microbiological Control of Water Treatment SystemsPresented by Christine Craig, Ph.D.Microbiology Consultant, ValSource, Inc.
Dr. Christine Craig is a microbiology consultant with ValSource, Inc. She has more than 15 years’ experience as a microbiologist with extensive expertise in pathogens and contamination control strategies. She has 6 years of specialized FDA regulatory experience performing risk-based product quality assessments of sterile and non-sterile drug products and has served as a microbiology subject matter expert (SME) within the Agency for contamination events, inspections, and 483 responses. As a microbiology consultant at ValSource, Inc., she applies her scientific and regulatory experiences to help ensure microbiological quality and safety in the pharmaceutical manufacturing industry. Dr. Craig’s goal and passion is to help industry meet or exceed FDA regulatory compliance requirements, while maintaining practical manufacturing processes. She holds a B.S in medical microbiology from University of California, Davis and a Ph.D. in molecular microbiology and immunology from Johns Hopkins University School of Public Health.
Josh Capsavage

Water Treatment System DesignPresentation by Josh CapsavageSenior Business Development Manager, Xylem
Josh Capsavage is a seasoned expert in water filtration, boasting a rich background encompassing quality control, process validation, and the engineering and design of water filtration systems tailored for both pharmaceutical and homeopathic sectors. With more than 18 years of extensive experience in sales and cGMP practices, he specializes in turn-key engineering, installation, and qualification of pure water systems. Recently appointed as the Senior Business Development Manager at Xylem Water, Josh directs his attention towards capital equipment and installation projects. Proudly based in Southern California, he resides with his wife Rachel and their three daughters, Ava, Emma, and Olivia.
William Yang, Ph.D.
Recent CGMP Deficiency Trends in Pharmaceutical Water Purification SystemsPresented by William Yang, Ph.D.Consumer Safety Officer, FDA
William Yang, Ph.D. is a consumer safety officer in the Office of Manufacturing Quality, Office of Compliance within the Center for Drug Evaluation and Research at FDA. He has been with FDA since 2016. Prior to FDA, he was a senior process development engineer at a biotechnology company.
Special Q&A with Two FDA Officials
Special Q&A with Two FDA Officials
A second FDA representative will join Dr. Yang for a special Q&A after his presentation. Tamara L. Ely, Branch Chief in the FDA’s Office of Manufacturing Quality, Office of Compliance within CDER has previously addressed the homeopathic industry at the AAHP GMP Compliance Seminar, October 2023.

Register

Early bird pricing is available through May 20, 2024 at 11:59pm EDT.

AAHP Semiannual Membership Meeting
2024-09-27 11:00 - 12:30
AAHP Semiannual Membership Meeting

Exclusive to AAHP Members is this semiannual briefing on the latest legal and regulatory issues from AAHP Legal Counselor Al Lorman, Esq. and on federal programs affecting your business from AAHP Lobbyist Pete Evich of Van Scoyoc Associates. Emerging issues and critical topics will be addresssed as necessary. Additionally, AAHP officers will provide updates on association projects.

Registration Now Open

Event Information

Virtual Only
Friday, September 27, 2024 from 11:00am-12:30pm EDT
Complimentary to AAHP Members, but registration is required
Closed to non-members

Please do not de-value your membership by sharing the link with non-members.
Meet our Guest Speaker: Jingjing Qian, PhD, Associate Professor, Harrison College of Pharmacy, Auburn University, Auburn, Alabama

Through the American Foundation for Pharmaceutical Education (AFPE), Dr. Qian will be working on a study proposed by AAHP on the safety of homeopathic drug products. The year-long study will examine adverse events and their characteristics in the FDA FAERS data, as well as quantitatively assess reporting risk of serious AEs associated with homeopathic drugs. Findings of this project will provide an up to date and fundamental safety profile of marketed homeopathic drugs, which further supports a well-informed legislative and regulatory environment for homeopathic products in the United States.
Also joining us will be AFPE president Ellen Woods who spoke at AAHP’s October 2023 membership meeting.

Who Should Attend at AAHP Member Companies

Government Affairs Team
Compliance Officers and Quality Assurance Team
Lab and Production Managers
Marketing Team
R&D Team
Company Executives, including CEOs

Agenda:

Welcome by Mark Land.
Study on the safety of homeopathic drug products by Jingjing Qian, PhD.
Legal and regulatory update from Al Lorman.
A look at how incoming administrations have in the past and may in the future affect our industry by Pete Evich.
New resource on history and future of homeopathy by Alissa Gould.
Q&A during each section.
Closing.

Questions from members are welcomed prior or during the event. Please contact AAHP Secretary Eric Foxman at email at Info@AAHP.Info or by voice message at 513-402-8847.

Registration Now Open

AAHP 2025 Annual Membership Meeting
2025-03-21 12:00 - 14:00
AAHP Annual Membership Meeting
Exclusive to AAHP Members is this annual briefing on the latest legal, regulatory, and federal issues affecting your business. Hear the impact of transitions from Washington insider and AAHP Lobbyist Pete Evich of Van Scoyoc Associates. Get updates on Alliance for Natural Health’s lawsuit against FDA from AAHP Legal Counselor Al Lorman. Participate in elections for AAHP’s Board of Directors and learn about AAHP’s future working structure as longtime AAHP Secretary Eric Foxman prepares for retirement.
RSVP Required
Event Information

Virtual Only
Friday, March 21, 2025 from 12:00pm-2:00pm EDT
Complimentary to AAHP Members, but registration is required
Closed to non-members

Please do not de-value your membership by sharing the link with non-members.
Who Should Attend at AAHP Member Companies

Government Affairs Team
Compliance Officers and Quality Assurance Team
Lab and Production Managers
Marketing Team
R&D Team
Company Executives, including CEOs

RSVP Required
Questions from members are welcomed prior or during the event. Please contact AAHP Secretary Eric Foxman at email at Info@AAHP.Info or by voice message at 513-402-8847.

2025 AAHP Semiannual Membership Meeting
2025-10-17 11:00 - 13:00 | Virtual
AAHP Semiannual Membership Meeting

Exclusive to AAHP Members is this semiannual briefing on the latest legal and regulatory issues from AAHP Legal Counselor Al Lorman, Esq. and on federal programs affecting your business from AAHP Lobbyist Pete Evich of Van Scoyoc Associates. Emerging issues and critical topics will be addressed. Additionally, AAHP officers will provide updates on association projects.

Registration Now Open

Event Information

Virtual via Zoom
Friday, October 17, 2025 from 11:00am-1:00pm EDT
Complimentary for AAHP Members (registration required)
Closed to non-members

Please do not de-value your membership by sharing the meeting link with non-members.
Who Should Attend at AAHP Member Companies

Government Affairs Team
Compliance Officers and Quality Assurance Team
Lab and Production Managers
Marketing Team
R&D Team
Company Executives, including CEOs

Agenda:
coming soon!
Please contact AAHP Secretary Eric L. Foxman via email at Info@AAHP.Info or by voice message at 513-402-8847 with questions or concerns.

Registration Now Open

AAHP 2026 Annual Membership Meeting (and Tribute to Eric Foxman)
2026-03-13 11:00 - 13:00
AAHP Annual Membership Meeting (and Tribute to Eric Foxman)
This two-part event starts with a business briefing exclusively for AAHP members. The second part is open to all in the homeopathic community as we honor Eric Foxman as he retires from AAHP.

Registration Now Open

Event Information

Virtual via Zoom
Friday, March 13, 2026
Complimentary
Registration required to receive your individual link

Who Should Attend at AAHP Member Companies

Government Affairs Team
Compliance Officers and Quality Assurance Team
Lab and Production Managers
Marketing Team
R&D Team
Company Executives, including CEOs

Agenda

President’s Welcome and Overview
Mark Land, AAHP President

AAHP Board Elections
Represent your member company in the open seats!

Legal Update
Al Lorman

ANSI Considerations for Homeopathic Products
Robert Melo, President of OHM Pharma and AAHP Board Member

Impactful Transitions
Pete Evich, Van Scoyoc Associates

Tribute to Secretary Eric Foxman
Honoring his retirement after 45 years of service to the homeopathic community

Please contact Association Manager Hayley Sotolotto via email at info@theaahp.org or by voice message at (413) 515-8133 with questions or concerns.

FDA Insights on GMP Violations & AAHP Homeopathic 483 Study Webinar
2026-06-10 12:00 - 13:30
FDA Insights on GMP Violations & AAHP Homeopathic 483 Study Webinar
Hear directly from FDA at AAHP’s upcoming webinar. Learn from the agency about compliance trends and inspection insights relevant to homeopathic drug manufacturers through AAHP’s ongoing Compliance Through Education program.
About the Program
GMP compliance-related issues remain the leading cause of FDA warning letters across the homeopathic industry. This webinar brings together regulatory perspective and industry expertise to help manufacturers better understand what FDA is looking for during inspections.
Attendees will gain practical insight into recent compliance actions, as well as a deeper understanding of common compliance gaps observed during facility inspections so companies can better prepare for their next inspection.
Event Information

Virtual via Zoom
Wednesday, June 10, 2026
12:00 PM – 1:30 ET
Complimentary to members and non-members

Registration Now Open

Featured Speakers

Francis Godwin, MBA
Director, Office of Manufacturing Quality (OMQ), Office of Compliance, CDER, FDA Francis Godwin will provide an FDA perspective on recentcompliance actions affecting homeopathic drug products, drawing on his extensive experience overseeing domestic and international CGMP compliance activities.

Eric L. Foxman, RPh (Ret.)
Senior Scientist, HPUS; Former AAHP Secretary and Board Member
With more than four decades of experience in the homeopathic industry, Eric Foxman will present a retrospective review of FDA 483 observations of inspections of homeopathic manufacturing sites, highlighting key trends and lessons to be learned.
What You Will Learn

Overview and examples of inspection compliance.

FDA’s hot topics which result in warning letters.

What inspection observations are made most often across the board.

What initial areas companies can focus on, which will make a positive difference in the 483 list of observations.

An overview of the breadth of observations for a second pass at increasing compliance before the next inspection occurs.

Who Should Attend
This seminar is a must-attend for domestic and foreign firms who manufacture, label, pack, or hold homeopathic drug products for sale in the United States.

Quality Staff

Legal & Regulatory Staff

Product Leads

Product R&D Staff

Company Leaders (President/CEO)

And those similarly responsible at your contract manufacturer

Please contact Association Manager Hayley Sotolotto via email at info@theaahp.org or by voice message at (413) 515-8133 with questions or concerns.
